Josephine Borrillo LLC Posts
Case study Spectrum Health System (2013). Engaging, responding within 24 hours and being HIPPA compliant on social media.
“Nothing about us without us” – patient partnership in medical conferences BMJ 2016; 354 Published 14 September 2016 Larry F. Chu et al. BMJ 2016;354:i3883. One key new highlight from this publication, in my opinion, is the dissemination of information from medical conferences by patients. The greater the participation of patients at medical conferences the greater the number of tweets.
Juror over drug prices puts patient advocacy groups in bind. By Katie Thomas New York Times September 27, 2016 Interesting take on what is the future of patient groups. Their absence in the debate of drug pricing and donations they receive from pharmaceutical companies leaves one to think what role these groups will play in the future.Comments closed
Health hashtags are transforming healthcare research online, are encouraging collaborations and can bring like minded thoughts together and turn tweets into conversations. Let’s take a look at how pharma is using healthcare hashtags in their online engagement.
1) Is pharma using health hashtags?
I have selected some random tweets from pharmaceutical companies and below each tweet you can find my comments on health hashtags.
I would have added a specific oncology hashtag.
I would have added psychology / mental health hashtags and also NAMI twitter handle.
If you can’t find a specific hashtag then submit one to Symplur.
I would have added some diabetes hashtags.
Overall, I truly believe pharma can do a better job in using health hashtags.
2) How can pharma benefit in using healthcare hashtags?
It is an excellent way of getting your brand seen and heard
It is an excellent way of getting relevant information to the right audience
It is an excellent way to get clinician perspectives, since clinicians use hashtags
It is an excellent way of discovering important voices in healthcare
It is an excellent way to put lay people in touch with recent research & researchers with people with lived experience
It is an excellent way to encourage collaborations, especially around health care topics
It is an excellent way to identify topics of discussion
It is an excellent way to help collaborators identify each other.
3) Getting the right hashtag?
Sometimes hashtags can be overly specific and too generic making them hard to find and hard to collaborate on specific topics. I have come across hashtags that only have one or a few tweets. The Symplur Healthcare Hashtag Project is free platform for patients, caregivers, advocates, doctors and other providers that connects them to relevant conversations and communities. Can’t find a specific health hashtag, you can also add a hashtag on Symplur.
4) So how can pharma adapt to health hash tagging effectively?
First and foremost be sure to research a health hashtag before using it. If it’s rarely used it won’t reach a large audience. Do some social listening to identify health hashtags and topics of discussion. Sometimes pharma companies create their own specific hashtags, but it’s hard to develop a following. The best approach would be to have brand teams include in their campaigns popular health hashtags.
5) What are some of the most common health hashtags?
Symplur is your go to resource. On their website you can identify Tweetchat hashtags, Conference related hashtags, Disease hashtags and health hashtags that are regularly used.
Symplur: http://www.symplur.comComments closed
Invest in CX to drive customer loyalty, advocacy and smiles. June 6, 2016 presentation by Kevin Cochrane at Gartner’s Digital Marketing Conference. We need to remember that behind every device is a real human being. Customer experience is learning about real people.
Is AI Better at Diagnosing Disease than a Doctor? August 18, 2016 by Steve Arar. A look at how artificial intelligence such as IBM Watson, Google Deepmind and Babylon are being used in the medical field.
Pharma working with traditional patient groups may look like old school or so yesterday. Inspiration for this blog post comes from the New York Times article by Tara Parker-Pope, How parents harnessed the power of social media to challenge Epipen prices (August 25, 2016). Today self forming groups is the new form of patient advocacy.
Q1: What is the difference between self forming patient/consumer groups and traditional patient/advocacy groups?
With the advent of internet and social media, self forming groups have been coming together to organise online. They tend to quickly organise themselves around a certain cause or issue, driven be a passion and motivation and tend to generally be short lived. Jackie Huba and Ben McConnell referred to these consumers and their voice as Citizen Marketers. Traditional structured patient advocate groups on the other hand can be defined as “an individual or an organization, often, though not always, concerned with one specific group of disorders. Typical advocacy activities may include: patient rights, matters of privacy, confidentiality or informed consent, patient representation, awareness building, support and education of patients, survivors and their carers”.
Q2: How are they different in driving patient advocacy?
Traditional patient groups, which are built as traditional hierarchical organisational structure, which in todays internet world can slow decisions. Membership, plays a key role in sustaining these patient organisations and as political clout. Also fundraising is a cornerstone to sustainability and several, if not all, are bound to pharmaceutical sponsorship. Whereas self forming groups come together when there is a need, have no internal reporting and no binds to sponsorship. In fast paced world of internet and social media they are free and more quick to respond to consumer needs.
Q3: Should pharma pay attention to these groups?
They are a force with which pharmaceutical companies must learn to contend with. The self forming groups have the ability to gain momentum very rapidly and have the potential to bring about change. Through crowdsourcing, broadcasting or making our opinions concerns heard across the internet or through social media can come about very easily. Crowdsourcing can be defined as: the process of obtaining needed services, ideas, or content by soliciting contributions from a large group of people, especially an online community, rather than from employees or suppliers. Each person’s contribution combines with those of others to achieve a cumulative result.
Q4: How could pharmaceutical companies work with these new groundswell groups?
Usually these groups are initiated by one influencer which has the capacity to bring together a crowd, through crowdsourcing. One way pharma could approach these groups would be to identify and build a relationship the influencer. Responding or engaging, which pharma is still trying to figure out, to the online discussion would also be vital. I also believe there is a possibility to work in both real and virtual spaces.
Q5: Do self forming groups have success?
Yes. Just take a look at the recent #epigate. A perfect catalyst for change initiated by one influencer, who had strong feeling of rage and anger, created a kick ass hashtag, and through crowdsourcing, was able to raise awareness and challenge epipen prices.
Outliers by Malcom Gladwell. In his book Outliers, Malcom Gladwell, highlights the 10,000 hour rule. People that are or have been successful is because of opportunities given to them and because they had dedicated 10,000 hours of practice that allowed them to be masters in their field.
Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites. Jennifer Tyrawski, MA and David C. DeAndrea, PhD. J Med Internet Res. 2015 Jun; 17(6): e130. Reviews how pharmaceutical companies are using eDTCA (electronic Direct to Consumer Advertising) on social media platforms. The research articles attempts to answer the following questions:
- To what extent is eDTCA present on pharmaceutical companies’ social media accounts?
- What is the nature of the user – generated content present on pharmaceutical companies’ social media accounts?
- To what extent are (1) drug efficacy claims, (2) personal testimonials, and (3) illegal pharmacies present when searching on popular social media sites for pharmaceutical drugs?
Turned off: how brands are annoying customers on social. The Q3 2016 Sprout Social IndexComments closed
Probably one of hardest and most often asked questions I get is “who owns or where should social media sit within an internal organization of a pharmaceutical company”?
Q1: So where should social media sit in an organization or who should own the responsibility of social media?
Social media across the years has come to play an important role in business. No longer is it just a nice to have, but rather it is an essential and integral part of any organization. In the same right social media has become a very sophisticated art and science that requires expertise, knowledge and the proper skill sets.
Therefore that is why today we speak of a “social media community management” that sits within an organization. Social media experts within pharmaceutical company should know social media platforms and audience best and what works and does not.
I believe that social media is not the responsibility of a sole team. Instead I see social media effecting the entire organization.
Owyang (2010) describes five different models in which organizations can organize internal for social media management . Dots represent those using social tools within an organization.
Most pharmaceutical companies appear to be, in my opinion, in the “Organic” structure. Why? From the outside it appears that messages are not really coordinated and branch offices are doing their own things. There does not appear to be coordination of company message, but more of isolated initiatives. HR is using social media for hiring. Communications is just an extension of the PR arm pushing press releases via different channels or communicating corporate messages / corporate reputation. Whereas, marketing, is using social media an arm’s length away by delegating to PR agencies, still need to work on how to use social media campaigns and product launches. Pharmaceutical is a very regulated industry, then even more so to have a more coordinated structure or multiple hub & spoke in place.
Q2: Should you be making your organization more social?
So how do you go about by making your organization more social. Start by building your expertise in house. Giving social media the priority it deserves within a product team. Start by identifying employees within your organization that are using social media and understand it. Get them on board since they will understand how social media works. This will give you the competitive advantage and knowledge.
Q3: What kind of model works bets in coordinating a response in a crisis?
Many departments will have a role in a crisis management. This is further evidence why social media should sit across the entire company and not to a sole team or department. In a crisis situation all teams and departments will want to act swiftly and messages must be coordinated. Each department and/or product team knows their product and responsibilities best.
Best way to manage this would be to a have dedicated social media person on the team that would know how to respond.
Q4: Who is the content expert and department expertise?
Content expert is the product team. Usually cross functional. But social media always is an expertise in it’s own. Departments are usually built around a certain function or supporting function that are experts with legal regulations and company policies and standard operating procedures.
Q5: What role does social maturity play in all this?
Social maturity plays a very important role in having in place an organization that incorporates social media. In my honest opinion I believe that pharmaceutical companies are still in the early stages of social maturity. They are aware that social media is changing our way of doing business. But there is lack of coordination. The marketing team has some agency Tweeting a conference. HR looking for potential recruits. PR posts a video or has blog about their corporate reputation. There is still doubt within the organization about the value of social media and what impact it can play in business.
Framework and matrix: the five ways companies organize for social business. Jeremiah Owyang. April 15, 2010.
Where does your social media department sit in your organization? By Alan Cronin November 3, 2015
The evolving social media department: a new approach to maximizing social ROI. By David Rush. Uly 24, 2014
Who “owns” social media data at your company? By Kevin Shively. July 26, 2016
Where should social media sit in an organization? By Will Bond. May 14, 2014
Blurred lines: who owns social media in the enterprise? By Sam Fiorello January 15, 2014
Why it doesn’t matter who “own” social media. By Jade Mangahis. January 28, 2015
Who should own social media? By Karima Catherine March 12, 2013Comments closed
Seven steps to successful customer experience measurement programs. How to define the right CX metrics and use them to improve CX . Forrester. Maxie Schmidt-Subramanian. February 4, 2016. Update to previously published report. Tips on designing a professional CX measurement program.
Digital drug safety surveillance: monitoring pharmaceutical products in twitter. Clark C. Freifeld, John S. Brownstein, Christopher M. Menone, Wenjie Bao, Ross Filice, Taha Kass-Hout, Nabarum Dasgupta. Drug Saf (2014) 37:343-350. The study sets out to study if there is there a concordance between Twitter posts mentioning a Adverse Event – like reaction and spontaneous reports received by a regulatory agency.
The rise of digital influence. March 21, 2012 By Brian Solis with Alan Webber The Altimeter Group. Excellent resource for defining and understanding who is the digital influencer. Also understanding the features that distinguish an influencer. What makes an influencer an influencer.Comments closed
@PfizerCongress describes it’s Twitter handle as “tweets are for European-based healthcare professionals only” and then goes on to explain “house rules”. Sorry @PfizerCongress welcome to Twitter world where the rules are those of engagement. Twitter has it’s set of house rules also.
Pharmaceutical companies feel that they can protect themselves from harm by putting out disclaimers such this. I have seen many of these kinds of disclaimers around on social media, but from all the articles I have been reading it appears that they meaningless.
Q1: Do disclaimers, such as in the @PfizerCongress, provide any real protection?
Pharmaceutical companies are working in a very regulated industry environment, I get that. FDA in the US and EMA in the EU. The fundamentals of social media are don’t say something that you should not be saying.
Q2: How are you going to protect or monitor responses to your tweets or re-tweets and who is following?
Disclaimers such as these do not protect you in this case either. I take it that the reason you are on Twitter in the first place is to share information with your audience. If people retweet and comment then you are engaging, which is even better. So @PfizerCongress you have to make sure the information you share is accurate and is according to policy set forth by the pharmaceutical regulatory agency in your jurisdiction. No matter what you will always be accountable.
Q3: How do people or professionals view them?
I just happened to see this in my twitter feed. But many of your followers may not see your disclaimer tweet at all. You will have to tweet several times a day for followers to see and take note. On top of everything this is not reality and followers will just steer away. This is sad because you may be sharing important medical updates from conferences that could interest many of your followers.
You are also not very transparent. I had to click on the link under your Twitter profile in order to get to the your house rules.
Q4: How does this impact or reflect your organization and reputation?
Not very good. It tells me you do not understand social media. It also makes me think that you could be doing a sloppy job in branding. Your information should be correct and according to pharmaceutical regulatory policies and if your job is done right then there is no need for disclaimers. This in the long will reflect on you as a company and your brand reputation.
Q5: Why are disclaimers useless?
It’s all on record, so always think before you post.
Disclaimer “these views are my own”. By Koka Sexton. March 31, 2015
Whose opinions are these now? Fix your brand and we won’t wonder. The Schumin Web jpnuary 5, 2014
With twitter Disclaimer, you can still get fired. By Brett Snider, Esq. On June 18, 2013
Why you should drop your twitter disclaimer. By Stuart Bruce March 11, 2014
The problem with adding “thoughts are my own” to your Twitter bio. By Claire deBell. January 29, 2013
Social media doesn’t sleep, so why should you? By Josephine Borrillo February 1, 2016Comments closed